Back

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

26 August 2017 (13:57 - 14:06)
Organised by:
Congress Presentation Part of: Can we teach heart failure drugs new tricks? Heart failure, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Michael Zile

Medical University of South Carolina, Charleston (United States of America)

9 More presentations in this session

Presentation thumbnail
Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET
Doctor Y. Mareev (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT.
Professor J. Cleland (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
The glucagon-like peptide 1 agonist liraglutide increases heart rate in heart failure patients
Doctor R. Tougaard (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Long-term outcome in myocardial infarction patients with heart failure treated with aldosterone receptor antagonist in relation to ejection fraction and kidney function
Doctor I. Lofman (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials
Doctor I. Pina (Philadelphia, US)
Abstract Slides Video

Access the full session

Session thumbnail
Can we teach heart failure drugs new tricks?

The Event

Event poster

ESC Congress 2017

26 August 2017 13:57 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources